On this episode of Going There, host Dr. Mike goes deep with singer, songwriter, rapper, and musician Kristine Meredith Flaherty, otherwise known as the multi-platinum and Grammy-nominated artist K.Flay.
Getting her start in the early aughts, K.Flay ‘s accomplished career continues with this year’s MONO, a record that, in part, covers her struggle with Sudden Sensorineural Hearing Loss and Labyrinthitis. Going completely deaf in one ear, Flaherty contemplated quitting music altogether — but as her batch of new songs prove, she persisted.
She talks about these struggles and the complicated feelings that came along with them, as well as her experience of getting sober. Flatherty has a complicated relationship and history with alcohol, not leastwise because of losing her father to addiction.
“There was some point — and it’s hard to know exactly what that point was — when I was like, ‘Oh, yeah, I want to be 10 feet outside of my brain, and there’s this stuff in a can, and it’ll help me leave.’ And that to me, I was like, ‘That’s not good. That’s not the point of this,'” she explains. “There was a period of time that I think alcohol did provide a connection, and then it stopped.”
Listen to K.Flay talk about her battles with hearing loss and alcohol in the new episode above, and watch a video segment below. Then make sure to like, review, and subscribe to Going There with Dr. Mike, presented by the Consequence Podcast Network and Sound Mind Live, wherever you get your podcasts.
Trouble seeing the video player above? Watch on YouTube.
Those in need of mental health assistance can check out the Sound Mind Live resources page for a list of helplines, community programs, therapy links, and more.
Season 4 of Going There with Dr. Mike is brought to you by AbbVie, who is driving the pursuit of better mental health. Over the last 30 years, AbbVie’s scientists and clinicians have worked to tackle the complexity of mental illness and today offer a portfolio of medicines and a pipeline of innovation that spans depression, anxiety, bipolar 1 disorder, and schizophrenia. To learn more about AbbVie’s work to support individuals throughout their mental health journey, please visit www.AbbVie.com or follow at AbbVie on Twitter, Facebook, Instagram, YouTube, and LinkedIn.
This episode is also brought to you by Alkermes. Alkermes is a global biopharmaceutical company developing innovative medicines in the field of neuroscience with products that treat alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder. To learn more, please visit Alkermes’ website or follow at Alkermes on Twitter and LinkedIn.